If you take blood pressure pills, you need to heed this warning
The MHRA has issued a drug safety warning regarding the risk of angioedema for patients taking ACE inhibitor blood pressure medications.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
The Medicines and Healthcare products Regulatory Agency (MHRA) has released a safety update concerning ACE inhibitors. The warning focuses on the risk of angioedema associated with these blood pressure medications.
Coverage from Pharmacy Business, The Pharmaceutical Journal, Pharmacy Magazine, and Doctors.net.uk emphasizes that the regulator is specifically alerting doctors to the possibility of delayed-onset angioedema. The Times has also reported on the warning for patients using these pills.
Further updates will likely depend on the MHRA's guidance to medical professionals and the resulting impact on patients using ACE inhibitors.
Synthesized by Archynetys from the headlines below under a strict no-invention contract. ✓ fact-checked: all claims supported by sources Updated 1d ago.
Quick answers
What is the MHRA warning about?
The MHRA has issued a safety update regarding the risk of angioedema linked to ACE inhibitors.
Who is the warning specifically directed toward?
The regulator has warned doctors about delayed-onset angioedema, while general reports alert patients taking blood pressure pills.
What type of medication is affected?
The warning applies to ACE inhibitors used for treating blood pressure.
Coverage (5)
- MHRA updates ACE inhibitors’ angioedema risk Pharmacy Business · 1d ago
- MHRA issues drug safety warning over ACE inhibitor side effect The Pharmaceutical Journal · 1d ago
- MHRA issues drug safety update for ACE inhibitors Pharmacy Magazine · 1d ago
- Regulator warns doctors over delayed-onset angioedema linked to ACE inhibitors Doctors.net.uk · 1d ago
- If you take blood pressure pills, you need to heed this warning The Times · 1d ago
Topics
Related trends
Researchers explore immunotherapy to revive natural hair color
Prime-and-pull vaccine may offer lasting genital herpes protection
A novel vaccine approach may soon offer long-term protection against genital herpes